Danvers, MA, United States of America

Matthew R Chin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Matthew R Chin

Introduction

Matthew R Chin is an accomplished inventor based in Danvers, MA (US). He has made significant contributions to the field of chemistry, particularly in the preparation of nucleosides. His work is characterized by a focus on innovative methods that enhance the efficiency of chemical processes.

Latest Patents

Matthew holds a patent for "Methods of preparing 1'-cyano nucleosides." This patent describes methods for synthesizing 1'-cyano nucleosides, including a compound of Formula (I). The innovative approach involves using a flow reactor to prepare the compound from a precursor, which is a compound of Formula (II-a). This patent showcases his expertise and commitment to advancing chemical methodologies. He has 1 patent to his name.

Career Highlights

Matthew is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to work on cutting-edge research and development projects that aim to improve health outcomes. His contributions to the company reflect his dedication to innovation in the pharmaceutical industry.

Collaborations

Matthew has collaborated with notable colleagues, including Pavel Robertovich Badalov and Stacy Bremner. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Matthew R Chin is a notable inventor whose work in the preparation of nucleosides has made a significant impact in the field of chemistry. His innovative methods and collaborations with esteemed colleagues highlight his commitment to advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…